NDAINTRAVENOUSINJECTABLEPriority Review
Approved
Oct 2005
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
6
Mechanism of Action
Nucleic Acid Synthesis Inhibitors
Pharmacologic Class:
Nucleoside Metabolic Inhibitor
Clinical Trials (5)
The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic Lymphoma
Started May 2024
Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Started Jun 2010
29 enrolled
Leukemia
Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL
Started Jun 2010
23 enrolled
Relapsed T-Cell Acute Lymphoblastic LeukemiaRelapsed T-Cell Lymphoblastic Lymphoma
Observational Study of Nelarabine in Children and Young Adults
Started Feb 2009
28 enrolled
Leukaemia, Lymphoblastic, Acute
Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg
Started Jan 2008
343 enrolled
Cancer